QDEL Earnings & Financial Statements
QuidelOrtho Corporation
$13.87
-$0.23(-1.63%)
58
Overall
60
Value
72
Tech
42
Quality
Market Cap
$951.14M
Volume
2.15M
52W Range
$9.92 - $35.58
Target Price
$13.50
QDEL earnings and financial statements: QuidelOrtho Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
QDEL Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.73B | $2.78B | $3.00B | $3.27B |
| Cost of revenue | $1.46B | $1.50B | $1.50B | $1.33B |
| Operating income | -$919.20M | -$1.96B | $139.10M | $843.70M |
| EBITDA | -$488.10M | -$1.51B | $575.70M | $1.10B |
| Net income | -$1.13B | -$2.05B | -$10.10M | $548.70M |
| EPS (diluted) | $-16.69 | $-30.54 | $-0.15 | $9.56 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $5.77B | $6.42B | $8.56B | $8.86B |
| Total liabilities | $3.85B | $3.44B | $3.56B | $3.92B |
| Shareholders’ equity | $1.92B | $2.98B | $5.01B | $4.93B |
| Cash and equivalents | $169.80M | $98.30M | $118.90M | $292.90M |
| Long-term debt | $2.63B | $2.31B | $2.45B | $2.62B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | $105.20M | $83.00M | $280.20M | $885.30M |
| Capital expenditure | -$188.20M | -$185.80M | -$209.30M | -$140.90M |
| Free cash flow | -$83.00M | -$112.10M | $70.90M | $744.40M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QDEL | $13.87 | -1.6% | 2.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |